Latest News about IBB
Recent news which mentions IBB
From Benzinga
 
   The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
   
  
  
  December 19, 2021
  From Benzinga
 
   Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
   
  
  
  December 17, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
   
  
  
  December 17, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
   
  
  
  December 16, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
   
  
  
  December 15, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
   
  
  
  December 14, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
   
  
  
  December 12, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
   
  
  
  December 10, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
   
  
  
  December 09, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
   
  
  
  December 08, 2021
  From Benzinga
 
   Smaller Biotech Stocks Ready to Perk Up
   
  
  
  December 07, 2021
  From ETF Trends
 
   The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
   
  
  
  December 07, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
   
  
  
  December 06, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
   
  
  
  December 03, 2021
  From Benzinga
 
   Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
   
  
  
  December 02, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
   
  
  
  December 02, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
   
  
  
  November 30, 2021
  From Benzinga
 
   Moderna’s Omicron Booster Strategy Lifts Biotechnology ETFs
   
  
  
  November 29, 2021
  From ETF Trends
 
   The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
   
  
  
  November 28, 2021
  From Benzinga
 
   Memeification of Biotech Stocks Shines Light on This ETF
   
  
  
  November 24, 2021
  From ETF Trends
 
   The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
   
  
  
  November 24, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
   
  
  
  November 23, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
   
  
  
  November 21, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
   
  
  
  November 19, 2021
  From Benzinga
 From MarketWatch
 
   The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
   
  
  
  November 17, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
